Zobrazeno 1 - 10
of 178
pro vyhledávání: '"1151Tins"'
Autor:
Kobayashi, Takashi1 (AUTHOR), Kanda, Shintaro1 (AUTHOR) skanda@shinshu-u.ac.jp, Fukushima, Toshirou1 (AUTHOR), Noguchi, Takuro1 (AUTHOR), Sekiguchi, Nodoka1 (AUTHOR), Koizumi, Tomonobu1 (AUTHOR)
Publikováno v:
Thoracic Cancer. Aug2021, Vol. 12 Issue 16, p2275-2278. 4p.
Autor:
Takashi Kobayashi, Shintaro Kanda, Toshirou Fukushima, Takuro Noguchi, Nodoka Sekiguchi, Tomonobu Koizumi
Publikováno v:
Thoracic Cancer, Vol 12, Iss 16, Pp 2275-2278 (2021)
Abstract We describe a case of an anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer with development of uterine metastasis after crizotinib and alectinib treatment. Gene analysis from the tissue of uterine metastasis revealed
Externí odkaz:
https://doaj.org/article/4797ef09b86e4644a2254d2f7defc5be
Autor:
Takashi Kobayashi, Takuro Noguchi, Shintaro Kanda, Nodoka Sekiguchi, Tomonobu Koizumi, Toshirou Fukushima
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 16, Pp 2275-2278 (2021)
Thoracic Cancer, Vol 12, Iss 16, Pp 2275-2278 (2021)
We describe a case of an anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer with development of uterine metastasis after crizotinib and alectinib treatment. Gene analysis from the tissue of uterine metastasis revealed the pres
Autor:
Fabbri, Laura1 (AUTHOR) laura.fabbri21@studio.unibo.it, Di Federico, Alessandro1,2 (AUTHOR) alessandrodifederico1@gmail.com, Astore, Martina1 (AUTHOR) martina.astore@studio.unibo.it, Marchiori, Virginia1 (AUTHOR) virginia.marchiori2@studio.unibo.it, Rejtano, Agnese1 (AUTHOR) agnese.rejtano@studio.unibo.it, Seminerio, Renata1 (AUTHOR) renata.seminerio@studio.unibo.it, Gelsomino, Francesco2 (AUTHOR), De Giglio, Andrea1,2 (AUTHOR) andrea.degiglio2@unibo.it
Publikováno v:
Diagnostics (2075-4418). Jan2024, Vol. 14 Issue 1, p48. 29p.
Autor:
Liu, Siming1,2 (AUTHOR), Huang, Chuan2 (AUTHOR), Huang, Chunhui2 (AUTHOR), Huang, Yaqi2 (AUTHOR), Yu, Yonghuan2 (AUTHOR), Wu, Guowu2 (AUTHOR), Guo, Fengqiu2 (AUTHOR), Jiang, Ying2 (AUTHOR), Wan, Shanhe2 (AUTHOR), Zhu, Zhengguang2 (AUTHOR), Tian, Yuanxin2 (AUTHOR), Zhu, Jianghua1 (AUTHOR) 14077785@qq.com, Zhang, Jiajie2 (AUTHOR) zhangjj@smu.edu.cn
Publikováno v:
Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2023, Vol. 38 Issue 1, p1-20. 20p.
Autor:
Kong, Yichao1,2 (AUTHOR) 2022011010022@stu.hznu.edu.cn, Jiang, Caihong1,2 (AUTHOR) 2022112025023@stu.hznu.edu.cn, Wei, Guifeng1,2 (AUTHOR) weiguifeng@stu.hznu.edu.cn, Sun, Kai1,2 (AUTHOR) 2021112012278@stu.hznu.edu.cn, Wang, Ruijie1,2 (AUTHOR) 2021112012297@stu.hznu.edu.cn, Qiu, Ting1,2 (AUTHOR) tingqiu@hznu.edu.cn
Publikováno v:
Molecules. Jun2023, Vol. 28 Issue 12, p4672. 39p.
Autor:
Cheon, So Yeong1,2 (AUTHOR), Kwon, Sunghark1 (AUTHOR) naritsuru@kku.ac.kr
Publikováno v:
International Journal of Molecular Sciences. Mar2023, Vol. 24 Issue 6, p5821. 18p.
Publikováno v:
Frontiers in Oncology; 2024, p1-14, 14p
Publikováno v:
Onkologia i Radioterapia; 2024, Vol. 18 Issue 7, p1-8, 8p
Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLC.
Autor:
Gemelli, Maria, Albini, Adriana, Catalano, Gianpiero, Incarbone, Matteo, Cannone, Maria, Balladore, Emanuela, Ricotta, Riccardo, Pelosi, Giuseppe
Publikováno v:
Expert Review of Anticancer Therapy; Jun2024, Vol. 24 Issue 6, p347-361, 15p